Class D
Judgment criteria: Long term implantation, life support, or contact with the circulatory system/central nervous system
Typical products: pacemakers, artificial joints, intravascular stents
Regulatory requirements: Strict review by CDSCO is required, usually requiring clinical trials to be conducted
4、 Comparison of Classification in Other Countries/Regions
US FDA
Classification logic: Class I (general control), Class II (special control), Class III (pre-market approval)
Typical products: Class I (tongue depressor), Class II (electrocardiograph), Class III (cochlear implant)
Regulatory differences: Class II requires 510 (k) pre certification, while Class III requires PMA pre-market approval
Japan
Classification logic: Class I (non management), Class II (self inspection), Class III (third-party audit), Class IV (approved by the Ministry of Health, Labour and Welfare)
Typical products: Class IV (pacemakers), Class III (CT machines)
5、 Classification confusion points and application suggestions
Differences in terminology
China's Class I ≠ EU's Class I: The risk of China's Class I is lower than that of EU Class I (such as China's Class I including some EU Class IIa products)
Class A/B ≠ Class I/II: Class A in India corresponds to Class I in China, while Class B corresponds to Class II in China, but there are still differences in the specific product classification
Actual application scenarios
Regulatory compliance: Exporting to China must comply with NMPA's I-III standards, while exporting to the EU must match MDR's I-III and IIa/IIb subdivisions
Product development: High risk devices (such as implants) require advance planning of clinical pathways, while low-risk devices can simplify the registration process
Market access: Class A products in India can be quickly launched, while Class D products require a 12-18 month approval cycle
Dynamic tracking mechanism
China updates the Classification Catalogue of Medical Devices every year, and the EU MDR continues to adjust the classification rules (such as the COVID-19 test downgrade in 2025). Enterprises need to regularly consult the official announcement.
Suggest using tools such as NMPA Medical Device Classification Definition Platform and EU EUDAMED Database to query product classifications in real-time
Medical EMC Solution